Evidence map›Paper›PMID 21967885›Full record

ArticlePharmacology, biochemistry, and behavior2012

A role for 5-HT1A receptors in the basolateral amygdala in the development of conditioned defeat in Syrian hamsters.

Kathleen E Morrison, Matthew A Cooper

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Lateralization of the 5-HTAmino acids · 2024
    Article
  2. StandardizedAntioxidants (Basel, Switzerland) · 2020
    Article
  3. Article
  4. LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HTThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  5. Article
  6. Article
  7. Input-specific contributions to valence processing in the amygdala.Learning & memory (Cold Spring Harbor, N.Y.) · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kathleen E MorrisonDepartment of Psychology, University of Tennessee, Knoxville, TN 37996-0900, USA. kmcinty1@utk.edu
Matthew A Cooper
University of Tennessee at Knoxville · US

Funding

Neural Mechanisms Underlying Stress-Induced Changes In BehaviorR21MH085230 · NIMH · UNIVERSITY OF TENNESSEE KNOXVILLE · PI COOPER, MATTHEW A · 2010 to 2011
$284k
NIMH NIH HHS R21 MH085230NIMH NIH HHS R21MH085230
6 · The paper itself

Abstract

The basolateral nucleus of the amygdala (BLA) is a key brain region regulating behavioral changes following stressful events, including social defeat. Previous research has shown that activation of serotonin (5-HT) 1A receptors in the BLA reduces conditioned fear and anxiety-like behavior. The objective of this study was to test whether 5-HT1A receptors in the BLA contribute to conditioned defeat in male Syrian hamsters (Mesocricetus auratus). We tested whether injection of the selective 5-HT1A receptor agonist flesinoxan (400 ng, 800 ng, or 1200 ng in 200 nl saline) into the BLA prior to social defeat would reduce the acquisition of conditioned defeat, and whether a similar injection prior to testing would reduce the expression of conditioned defeat. We also tested whether injection of the selective 5-HT1A receptor antagonist WAY-100635 (400 ng or 1600 ng in 200 nl saline) into the BLA prior to social defeat would enhance the acquisition of conditioned defeat, and whether a similar injection prior to testing would enhance the expression of conditioned defeat. We found that injection of flesinoxan into the BLA decreased both the acquisition and expression of conditioned defeat. However, injection of WAY-100635 into the BLA did not alter the acquisition or expression of conditioned defeat. These data indicate that pharmacological activation of 5-HT1A receptors in the BLA is sufficient to impair the acquisition and expression of conditioned defeat. Our results suggest that pharmacological treatments that activate 5-HT1A receptors in the BLA are capable of reducing the development of stress-induced changes in behavior.

Indexed as

AmygdalaAnimalsAnti-Anxiety AgentsAnxietyBehavior, AnimalConditioning, PsychologicalCricetinaeDisease Models, AnimalDose-Response Relationship, DrugMaleMesocricetusMolecular Targeted TherapyNerve Tissue ProteinsNeuronsPiperazinesPyridinesAnti-Anxiety AgentsflesinoxanN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamideNerve Tissue ProteinsPiperazinesPyridinesReceptor, Serotonin, 5-HT1ASerotonin 5-HT1 Receptor AgonistsSerotonin 5-HT1 Receptor Antagonists

Identifiers

PMID21967885
PMCPMC3242817
OpenAlexW2035359697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.